Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X

Basilea expands ongoing Phase I/IIa clinical trial of BAL101553 to include glioblastoma patients

Go Top